BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PIM1, PIM, 5292, ENSG00000137193, P11309
58 results:

  • 1. Imparting aromaticity to 2-pyridone derivatives by
    Abdelaziz ME; El-Miligy MMM; Fahmy SM; Abu-Serie MM; Hazzaa AA; Mahran MA
    J Enzyme Inhib Med Chem; 2024 Dec; 39(1):2304044. PubMed ID: 38230430
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. pim1 targeted degradation prevents the emergence of chemoresistance in prostate cancer.
    Torres-Ayuso P; Katerji M; Mehlich D; Lookingbill SA; Sabbasani VR; Liou H; Casillas AL; Chauhan SS; Serwa R; Rubin MR; Marusiak AA; Swenson RE; Warfel NA; Brognard J
    Cell Chem Biol; 2024 Feb; 31(2):326-337.e11. PubMed ID: 38016478
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Age at Menopause and the Risk of Stroke: Observational and Mendelian Randomization Analysis in 204 244 Postmenopausal Women.
    Tschiderer L; Peters SAE; van der Schouw YT; van Westing AC; Tong TYN; Willeit P; Seekircher L; Moreno-Iribas C; Huerta JM; Crous-Bou M; Söderholm M; Schulze MB; Johansson C; Själander S; Heath AK; Macciotta A; Dahm CC; Ibsen DB; Pala V; Mellemkjær L; Burgess S; Wood A; Kaaks R; Katzke V; Amiano P; Rodriguez-Barranco M; Engström G; Weiderpass E; Tjønneland A; Halkjær J; Panico S; Danesh J; Butterworth A; Onland-Moret NC
    J Am Heart Assoc; 2023 Sep; 12(18):e030280. PubMed ID: 37681566
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Estimations of smoking-attributable mortality in Spain at a regional level: comparison of two methods.
    Rey-Brandariz J; Blanco-Ferreiro A; Varela-Lema L; Santiago-Pérez MI; Ruano-Ravina A; Galán I; Candal-Pedreira C; Pérez-Ríos M
    Ann Epidemiol; 2023 Jun; 82():77-83.e3. PubMed ID: 37037345
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Trends in Survival Rates of Non-Small Cell lung cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
    Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
    JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Development and validation of a nomogram to predict the risk of potentially inappropriate medication use in older lung cancer outpatients with multimorbidity.
    Tian F; Chen Z; Wu B
    Expert Opin Drug Saf; 2023; 22(8):725-732. PubMed ID: 36803141
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of polypharmacy and potential drug-drug interactions with adverse treatment outcomes in older adults with advanced cancer.
    Mohamed MR; Mohile SG; Juba KM; Awad H; Wells M; Loh KP; Flannery M; Culakova E; Tylock RG; Ramsdale EE
    Cancer; 2023 Apr; 129(7):1096-1104. PubMed ID: 36692475
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Discovery of new pyridine-quinoline hybrids as competitive and non-competitive pim-1 kinase inhibitors with apoptosis induction and caspase 3/7 activation capabilities.
    El-Miligy MMM; Abdelaziz ME; Fahmy SM; Ibrahim TM; Abu-Serie MM; Mahran MA; Hazzaa AA
    J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2152810. PubMed ID: 36629075
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Design, synthesis, evaluation of new 3-acetylisoxazolines and their hybrid analogous as anticancer agents: In vitro and in silico analysis.
    Fawzi M; Oubella A; Bimoussa A; Bamou FZ; Khdar ZA; Auhmani A; Riahi A; Robert A; Morjani H; Itto MYA
    Comput Biol Chem; 2022 Jun; 98():107666. PubMed ID: 35381466
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Use of potentially inappropriate medication in older patients with lung cancer at the end of life.
    Ham L; Geijteman ECT; Aarts MJ; Kuiper JG; Kunst PWA; Raijmakers NJH; Visser LE; van Zuylen L; Brokaar EJ; Fransen HP
    J Geriatr Oncol; 2022 Jan; 13(1):53-59. PubMed ID: 34366274
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Synthesis of Heterocyclic Compounds Derived From Dimedone and their Anti-tumor and Tyrosine Kinase Inhibitions.
    Mohareb RM; Manhi FM; Abdelwahab A
    Acta Chim Slov; 2020 Mar; 67(1):83-95. PubMed ID: 33558929
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Gene expression in circulating tumor cells reveals a dynamic role of EMT and PD-L1 during osimertinib treatment in NSCLC patients.
    Ntzifa A; Strati A; Kallergi G; Kotsakis A; Georgoulias V; Lianidou E
    Sci Rep; 2021 Jan; 11(1):2313. PubMed ID: 33504904
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. pim Kinases Promote Survival and Immune Escape in Primary Mediastinal Large B-Cell Lymphoma through Modulation of JAK-STAT and NF-κB Activity.
    Szydłowski M; Dębek S; Prochorec-Sobieszek M; Szołkowska M; Tomirotti AM; Juszczyński P; Szumera-Ciećkiewicz A
    Am J Pathol; 2021 Mar; 191(3):567-574. PubMed ID: 33307035
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Polypharmacy among older advanced lung cancer patients taking EGFR tyrosine kinase inhibitors.
    Hakozaki T; Matsuo T; Shimizu A; Ishihara Y; Hosomi Y
    J Geriatr Oncol; 2021 Jan; 12(1):64-71. PubMed ID: 32952094
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Novel, Selective Inhibitors of USP7 Uncover Multiple Mechanisms of Antitumor Activity
    Ohol YM; Sun MT; Cutler G; Leger PR; Hu DX; Biannic B; Rana P; Cho C; Jacobson S; Wong ST; Sanchez J; Shah N; Pookot D; Abraham B; Young K; Suthram S; Marshall LA; Bradford D; Kozon N; Han X; Okano A; Maung J; Colas C; Schwarz J; Wustrow D; Brockstedt DG; Kassner PD
    Mol Cancer Ther; 2020 Oct; 19(10):1970-1980. PubMed ID: 32788207
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High Expression of NEK2 and pim1, but Not pim3, Is Linked to an Aggressive Phenotype of Bronchopulmonary Neuroendocrine Neoplasms.
    Motylewska E; Braun M; Stępień H
    Endocr Pathol; 2020 Sep; 31(3):264-273. PubMed ID: 32504181
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Synthesis and Anti-Proliferative Evaluations of New Heterocyclic Derivatives Using 5,6,8,9-Tetrahydropyrazolo[5,1-b]quinazolin-7(3H)-one Derivatives Derived from Cyclohexa-1,4-dione.
    Mahmoud MAA; Alsharif MA; Mohareb RM
    Anticancer Agents Med Chem; 2021; 21(4):468-486. PubMed ID: 32445457
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Determining the Relative Gene Expression Level of Hypoxia Related Genes in Different cancer Cell Lines.
    Baqlouq L; Zihlif M; Hammad H; Thaib TMA
    Curr Mol Pharmacol; 2021; 14(1):52-59. PubMed ID: 32436837
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Polypharmacy, Inappropriate Medication Use, and Drug Interactions in Older Korean Patients with cancer Receiving First-Line Palliative Chemotherapy.
    Hong S; Lee JH; Chun EK; Kim KI; Kim JW; Kim SH; Lee YG; Hwang IG; Kim JY; Koh SJ; Ko YH; Shin SH; Woo IS; Kim TY; Baek JY; Kim HJ; Kim HJ; Lee MA; Kwon JH; Hong YS; Ryoo HM; Kim JH
    Oncologist; 2020 Mar; 25(3):e502-e511. PubMed ID: 32162799
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. pim kinases alter mitochondrial dynamics and chemosensitivity in lung cancer.
    Chauhan SS; Toth RK; Jensen CC; Casillas AL; Kashatus DF; Warfel NA
    Oncogene; 2020 Mar; 39(12):2597-2611. PubMed ID: 31992853
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.